Back to dashboard
Medicare AdvantagePrior AuthMedium impact

Trulance® (plecanatide) (Revised)

Humana·Gastroenterology, Family Medicine, Internal Medicine +1 more·Medicare Advantage
Effective date
Jan 1, 2024
We identified it
Jun 24, 2026
Days to comply

Summary

Humana Medicare Advantage has updated prior authorization requirements for Trulance (plecanatide) tablets used to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. Patients must have tried or been unable to tolerate specific first-line medications before Trulance will be approved.

Action Required

Action needed
Immediately: When prescribing Trulance for Medicare Advantage patients, ensure providers document prior treatment, intolerance, or contraindication to Linzess (linaclotide) for IBS-C patients, or both Linzess and lubiprostone for chronic constipation patients. Submit prior authorization requests with this documentation. Claims without proper prior auth will be denied.